Bio-Techne Corp (TECH)
71.88
-0.65
(-0.90%)
USD |
NASDAQ |
Mar 18, 16:00
71.88
0.00 (0.00%)
After-Hours: 20:00
Bio-Techne Debt to Equity Ratio: 0.2276 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.2276 |
September 30, 2023 | 0.2202 |
June 30, 2023 | 0.178 |
March 31, 2023 | 0.1958 |
December 31, 2022 | 0.1095 |
September 30, 2022 | 0.1511 |
June 30, 2022 | 0.1504 |
March 31, 2022 | 0.1511 |
December 31, 2021 | 0.1657 |
September 30, 2021 | 0.1831 |
June 30, 2021 | 0.2184 |
March 31, 2021 | 0.1399 |
December 31, 2020 | 0.1521 |
September 30, 2020 | 0.2249 |
June 30, 2020 | 0.2583 |
March 31, 2020 | 0.3251 |
December 31, 2019 | 0.2894 |
September 30, 2019 | 0.4139 |
June 30, 2019 | 0.4334 |
March 31, 2019 | 0.4556 |
December 31, 2018 | 0.4974 |
September 30, 2018 | 0.5061 |
June 30, 2018 | 0.3142 |
March 31, 2018 | 0.3709 |
December 31, 2017 | 0.3633 |
Date | Value |
---|---|
September 30, 2017 | 0.3516 |
June 30, 2017 | 0.362 |
March 31, 2017 | 0.3945 |
December 31, 2016 | 0.3899 |
September 30, 2016 | 0.3878 |
June 30, 2016 | 0.1083 |
March 31, 2016 | 0.1895 |
December 31, 2015 | 0.1945 |
September 30, 2015 | 0.2008 |
June 30, 2015 | 0.0909 |
March 31, 2015 | 0.189 |
December 31, 2014 | 0.1913 |
September 30, 2014 | 0.1575 |
June 30, 2014 | 0.0163 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.1095
Minimum
Dec 2022
0.4556
Maximum
Mar 2019
0.2322
Average
0.2071
Median
Debt to Equity Ratio Benchmarks
Agilent Technologies Inc | 0.4129 |
Revvity Inc | 0.4953 |
Twist Bioscience Corp | 0.00 |
AIM ImmunoTech Inc | 0.00 |
Protalix BioTherapeutics Inc | 0.6033 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 2.731B |
Total Liabilities (Quarterly) | 767.19M |
Shareholders Equity (Quarterly) | 1.964B |
Current Ratio | 4.368 |
Net Debt Paydown Yield | -0.30% |